Clinical Trial Update: A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema

View source ↗

Summary

This clinical trial update reports on a single-center study evaluating high-frequency pegaptanib to rapidly restore VEGF balance in diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Retina Institute of Hawaii | Conditions: Diabetic Macular Edema | Status: AVAILABLE